Robert Paul M.D., Ph.D.
Net Worth

Last updated:

What is Robert Paul M.D., Ph.D. net worth?

The estimated net worth of Dr. Robert Paul M.D., Ph.D. is at least $15,809,021 as of 9 Aug 2021. He owns shares worth $501,443 as insider, has earned $11,896,578 from insider trading and has received compensation worth at least $3,411,000 in Alector, Inc..

What is the salary of Robert Paul M.D., Ph.D.?

Dr. Robert Paul M.D., Ph.D. salary is $568,500 per year as Advisor in Alector, Inc..

How old is Robert Paul M.D., Ph.D.?

Dr. Robert Paul M.D., Ph.D. is 57 years old, born in 1968.

What stocks does Robert Paul M.D., Ph.D. currently own?

As insider, Dr. Robert Paul M.D., Ph.D. owns shares in one company:

Company Title Shares Price per share Total value
Alector, Inc. (ALEC) Advisor 234,319 $2.14 $501,443

What does Alector, Inc. do?

Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis diseases; and AL101 that is in Phase I clinical trial for the treatment of neurodegenerative diseases, including Alzheimer's and Parkinson's diseases. The company also offers AL002, a product candidate that is in Phase II clinical trial for the treatment of Alzheimer's disease; and AL003, which is in Phase I clinical trial for the treatment of Alzheimer's disease. In addition, its products in development stage include AL044 that targets MS4A4A, a risk gene for Alzheimer's disease. Alector, Inc. has a collaboration agreement with Adimab, LLC for the research and development of antibodies; and a strategic collaboration agreement with GlaxoSmithKline plc for the development and commercialization of monoclonal antibodies, such as AL001 and AL101 to treat neurodegenerative diseases. The company was founded in 2013 and is headquartered in South San Francisco, California.

ALEC logo
ALEC
Alector, Inc.
$2.14

Robert Paul M.D., Ph.D. insider trading

Alector, Inc.

Dr. Robert Paul M.D., Ph.D. has made 44 insider trades between 2019-2021, according to the Form 4 filled with the SEC. Most recently he sold 22,950 units of ALEC stock worth $630,689 on 9 Aug 2021.

The largest trade he's ever made was exercising 43,800 units of ALEC stock on 22 Mar 2021. As of 9 Aug 2021 he still owns at least 234,319 units of ALEC stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 22,950 $27.48 $630,689
Option
Employee Stock Option (right to buy) 22,950 $11.82 $271,200
Option
Common Stock 22,950 $11.82 $271,200
Sale
Common Stock 22,950 $27.48 $630,689
Option
Common Stock 29,749 $11.82 $351,544
Sale
Common Stock 29,749 $38.29 $1,139,089
Option
Common Stock 29,749 $11.82 $351,544
Option
Common Stock 29,749 N/A N/A
Sale
Common Stock 29,749 N/A N/A
Option
Employee Stock Option (right to buy) 29,749 N/A N/A
Option
Employee Stock Option (right to buy) 29,749 $11.82 $351,544
Sale
Common Stock 30,000 N/A N/A
Option
Common Stock 30,000 N/A N/A
Option
Employee Stock Option (right to buy) 30,000 N/A N/A
Sale
Common Stock 30,000 $37.71 $1,131,270
Sale
Common Stock 30,000 N/A N/A
Option
Employee Stock Option (right to buy) 17,326 N/A N/A
Option
Common Stock 17,326 N/A N/A
Sale
Common Stock 26,726 N/A N/A
Option
Common Stock 4,600 $22.19 $102,051
Sale
Common Stock 4,600 $22.19 $102,051
Option
Employee Stock Option (right to buy) 4,600 $22.19 $102,051
Option
Employee Stock Option (right to buy) 30,000 $9.15 $274,500
Option
Common Stock 30,000 $9.15 $274,500
Sale
Common Stock 30,000 $22.07 $661,950
Option
Common Stock 30,000 $9.15 $274,500
Option
Employee Stock Option (right to buy) 30,000 $9.15 $274,500
Sale
Common Stock 19,175 $19.91 $381,678
Sale
Common Stock 19,175 $19.91 $381,678
Option
Common Stock 19,175 $9.15 $175,451
Option
Employee Stock Option (right to buy) 19,175 $9.15 $175,451
Option
Employee Stock Option (right to buy) 14,975 $9.15 $137,021
Option
Common Stock 14,975 $9.15 $137,021
Option
Employee Stock Option (right to buy) 14,975 $9.15 $137,021
Sale
Common Stock 14,975 $18.14 $271,676
Option
Common Stock 14,975 $9.15 $137,021
Option
Common Stock 4,200 $9.15 $38,430
Option
Employee Stock Option (right to buy) 4,200 $9.15 $38,430
Sale
Common Stock 4,200 $18.04 $75,785
Option
Employee Stock Option (right to buy) 4,200 $9.15 $38,430
Option
Common Stock 4,200 $9.15 $38,430
Option
Employee Stock Option (right to buy) 22,300 $11.82 $263,519
Sale
Common Stock 22,300 $19.51 $435,118
Option
Common Stock 22,300 $11.82 $263,519
Option
Common Stock 22,300 $11.82 $263,519
Sale
Common Stock 22,300 $19.51 $435,118
Option
Employee Stock Option (right to buy) 22,300 $11.82 $263,519
Option
Employee Stock Option (right to buy) 22,300 $8.44 $188,145
Option
Common Stock 22,300 $11.82 $263,519
Option
Common Stock 13,800 N/A N/A
Sale
Common Stock 13,800 N/A N/A
Option
Common Stock 30,000 $8.16 $244,800
Option
Employee Stock Option (right to buy) 43,800 $15.19 $665,103
Option
Employee Stock Option (right to buy) 43,800 $4.08 $178,704
Sale
Common Stock 30,000 $23.2 $696,030
Sale
Common Stock 30,000 $23.2 $696,030
Sale
Common Stock 19,175 N/A N/A
Option
Employee Stock Option (right to buy) 19,175 $4.08 $78,234
Option
Common Stock 19,175 $5.07 $97,217
Option
Common Stock 19,175 N/A N/A
Sale
Common Stock 19,175 $20.81 $399,051
Option
Employee Stock Option (right to buy) 19,175 N/A N/A
Option
Common Stock 19,175 N/A N/A
Option
Common Stock 27,308 $5.07 $138,452
Option
Common Stock 27,308 $9.15 $249,868
Option
Employee Stock Option (right to buy) 27,308 $4.08 $111,417
Sale
Common Stock 27,308 $18 $491,544
Option
Employee Stock Option (right to buy) 27,308 $9.15 $249,868
Sale
Common Stock 30,000 $18.01 $540,240
Option
Employee Stock Option (right to buy) 30,000 $9.15 $274,500
Option
Common Stock 30,000 $9.15 $274,500
Option
Common Stock 30,000 $9.15 $274,500
Option
Common Stock 8,567 N/A N/A
Option
Employee Stock Option (right to buy) 8,567 $9.15 $78,388
Option
Employee Stock Option (right to buy) 8,567 $9.15 $78,388
Sale
Common Stock 8,567 N/A N/A
Option
Common Stock 8,567 $9.15 $78,388
Option
Employee Stock Option (right to buy) 30,000 $9.15 $274,500
Option
Employee Stock Option (right to buy) 30,000 $9.15 $274,500
Sale
Common Stock 30,000 N/A N/A
Option
Common Stock 30,000 N/A N/A
Sale
Common Stock 10,000 $11.47 $114,700
Sale
Common Stock 10,000 $29.67 $296,650
Sale
Common Stock 10,000 $26.98 $269,770
Sale
Common Stock 10,000 $18.26 $182,600
Sale
Common Stock 10,000 N/A N/A
Sale
Common Stock 10,000 $23 $229,980
Sale
Common Stock 10,000 $29.41 $294,050
Option
Stock Option (right to buy) 10,000 $8.16 $81,600
Sale
Common Stock 10,000 $8.16 $81,600
Option
Common Stock 10,000 $8.16 $81,600
Option
Common Stock 8,000 $8.16 $65,280
Option
Stock Option (right to buy) 8,000 $8.16 $65,280
Sale
Common Stock 8,000 $8.16 $65,280
Option
Stock Option (right to buy) 6,000 $8.16 $48,960
Sale
Common Stock 6,000 $24.72 $148,320
Option
Common Stock 6,000 $8.16 $48,960
Sale
Common Stock 10,000 $18.67 $186,700
Sale
Common Stock 10,000 $20.03 $200,300
Sale
Common Stock 10,000 $15.93 $159,300
Sale
Common Stock 10,000 $14.68 $146,800
Option
Common Stock 4,000 $8.16 $32,640
Option
Stock Option (right to buy) 4,000 $8.16 $32,640
Sale
Common Stock 4,000 $8.16 $32,640
Sale
Common Stock 10,000 $19.08 $190,800
Option
Stock Option (right to buy) 916 $16 $14,656
Sale
Common Stock 1,832 $16 $29,312
Option
Common Stock 916 $16 $14,656
Option
Stock Option (right to buy) 1,084 $8.16 $8,845
Option
Common Stock 1,084 $8.16 $8,845
Sale
Common Stock 2,168 $12.08 $26,189
Sale
Common Stock 10,000 $14.19 $141,900

Alector key executives

Alector, Inc. executives and other stock owners filed with the SEC: